Earnings call transcript: Altisource misses Q3 2026 EPS forecast as shares fall premarket

Altisource reported Q3 2026 adjusted EPS of $0.13, 27.8% below the $0.18 consensus, and revenue of $49.8 million, 1.6% below forecasts; shares fell 3.9% premarket to $5.43. Revenue still grew 26% year over year and adjusted EBITDA rose 17% to $4.3 million, while gross margin declined to 23.4% amid mix pressure and implementation costs. Management expects Q4 adjusted EBITDA to exceed Q3 and reiterated its goal of $45 million in run-rate adjusted EBITDA by Q4 2028, citing customer wins, operating leverage and efficiency initiatives.

Analysis

The key issue is growth quality, not the small revenue miss. ASPS is adding business outside its legacy customer relationships, which lowers concentration risk, but the faster-growing origination work is lower margin and is currently diluting gross profit. The bull case therefore depends on new wins maturing into incremental EBITDA faster than implementation costs and legacy runoff erode contribution. Management’s margin-expansion narrative is plausible, but remains a forecast rather than demonstrated operating leverage; AI benefits are even less measurable at this stage.

The $45 million run-rate EBITDA objective is a demanding execution marker: at Q3’s pace, annualized EBITDA is roughly $17 million, so the target requires substantial scaling by late 2028. Pipeline and asset inventory are leading indicators, not booked revenue; conversion timing and unit economics matter more than headline pipeline growth. Near term, the stated expectation for higher Q4 EBITDA provides a check, but SBC may rebound from a potentially unusually low Q3 level and obscure underlying progress.

The premarket decline alone does not establish capitulation, and the stock’s prior weakness may already discount some execution risk. Contrarian opportunity exists only if margins stabilize while non-legacy wins convert; otherwise, revenue growth can coexist with weak earnings conversion. Over 6–18 months, a sustained rise in default activity could add volume, but remains upside rather than a base-case substitute for execution.

Key Decisions for Investors

• No immediate short after the premarket move: risk/reward is unclear without volume context, and Q4 EBITDA guidance creates a near-term counter-catalyst. Reassess after the Q4 report.
• Keep ASPS on a conditional long watchlist, not a conviction position. Consider entry only if the next report shows sequential EBITDA growth alongside gross-margin stabilization and evidence that recent customer wins are converting.
• Treat the $45 million objective and reported pipeline as unverified upside until conversion, retention, and incremental margins are visible in filings. Verify whether implementation spending and legacy runoff are declining as new revenue scales.
• Falsification: reduce or avoid the long thesis if Q4 EBITDA fails to exceed Q3, or if subsequent results show continued gross-margin erosion without improving EBITDA conversion; a sustained margin recovery would weaken the cautious view.